(Q82231893)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20007626%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

New opportunities for the management and therapy of hepatitis C in correctional settings (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20007626%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

C Kent Martin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20007626%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Jeffrey E Hostetter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20007626%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

John J Hagan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20007626%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20007626%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Public Health

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20007626%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20007626%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20007626%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

13-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20007626%20AND%20SRC:MED&resulttype=core&format=json

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

15 January 2020

cites work

1 reference

12 December 2020

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

1 reference

12 December 2020

A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C.

1 reference

12 December 2020

The role of consensus interferon in the current treatment of chronic hepatitis C viral infection

1 reference

12 December 2020

Treatment of chronic hepatitis C in a state correctional facility

1 reference

12 December 2020

Treating hepatitis C in the prison population is cost-saving

1 reference

12 December 2020

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

12 December 2020

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

12 December 2020

Cost-effectiveness of hematologic growth factors for anemia occurring during hepatitis C combination therapy

1 reference

12 December 2020

HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response

1 reference

12 December 2020

Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.

1 reference

12 December 2020

Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C.

1 reference

12 December 2020

Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.

1 reference

12 December 2020

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

12 December 2020

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

12 December 2020

Interferon alfacon-1: a novel interferon for the treatment of chronic hepatitis C.

1 reference

12 December 2020

Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations

1 reference

12 December 2020

Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?

1 reference

12 December 2020

Growth factors during HCV therapy may be "cost-effective", but are they "effective"?

1 reference

12 December 2020